Follicular Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Follicular Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors [NA]
A Mayo Clinic-led clinical trial update describes a study evaluating health and wellness coaching to improve adherence to healthy habits and…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial [NA]
A ClinicalTrials.gov update for the Thrive Track trial aimed at managing emotional support for young adults with thyroid cancer, melanoma, a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
A clinical trial update for a study assessing urinary exosomal biomarkers (thyroglobulin and galectin-3) to predict prognosis and monitor th…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
A Mayo Clinic-sponsored clinical study is evaluating the 18F-TFB PET/CT scan for imaging differentiated thyroid cancers; the trial is curren…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation [Phase 2]
Phase 2 clinical trial evaluating the combination of vemurafenib and cobimetinib in high-risk differentiated thyroid carcinoma with BRAFV600…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update indicating that XL092 for locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer …
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Observational clinical trial update analyzing the transcriptome and mutational status of thyroid carcinomas of follicular origin across diff…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC [Phase 2]
Phase 2 trial assessing restoration of I-131 uptake with selpercatinib in RET fusion-positive, radioiodine-refractory thyroid cancer; curren…